Anthony Woolf News Today

Golden managing partner Matt Golden said it was a ‘clean deal’ free of complex structured terms that financiers have increasingly demanded from startups to guarantee them a larger share of proceeds when they sell

Toronto-based BenchSci, which helps pharmaceutical firms accelerate R&D using AI, has announced $95 million CAD in Series D funding.

Study estimates there will be over 800 million cases of low back pain in 2050, a 36 percent increase from 2020. With an aging population, researchers say we must put the brakes on low back pain cases before the burden becomes too great for our healthcare system.

The study found that since 2017, the number of low back pain cases has ticked over to more than half a billion people.

A recent study published in the Lancet Rheumatology journal predicts that over 840 million people worldwide will experience back pain by the year 2050. The increase in cases is mainly attributed to population growth and an aging population

The continued lack of a consistent approach to back pain treatment, and limited treatment options have researchers concerned that this will lead to a healthcare crisis, as low back pain is the leading cause of disability in the world, they said.

Study estimates there will be over 800 million cases of low back pain in 2050, a 36 percent increase from 2020. With an ageing population, researchers say we must ‘put the brakes’ on low back pain cases before the burden becomes too great for our healthcare system.

More than 840 million people worldwide will suffer back pain by 2050, largely due to population increase and the ageing people, according to a modelling study published in the Lancet Rheumatology journal.

More than 840 million people worldwide will suffer back pain by 2050, largely due to population increase and the ageing people, according to a modelling study published in the Lancet Rheumatology journal.